{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:31:48Z","timestamp":1777498308054,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22ck0106609"],"award-info":[{"award-number":["JP22ck0106609"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22ama221403"],"award-info":[{"award-number":["JP22ama221403"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25ck0106854"],"award-info":[{"award-number":["JP25ck0106854"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22KK0133"],"award-info":[{"award-number":["JP22KK0133"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K08927"],"award-info":[{"award-number":["JP20K08927"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 22H031315"],"award-info":[{"award-number":["JP 22H031315"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.mrfmmm.2025.111915","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T23:45:14Z","timestamp":1758152714000},"page":"111915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Analysis of TERT promoter hotspot mutations using droplet digital PCR in\u00a0hepatoblastoma and hepatocellular carcinoma"],"prefix":"10.1016","volume":"831","author":[{"given":"Yoko","family":"Hiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isamu","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Touge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Fukazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9179-5037","authenticated-orcid":false,"given":"Eiso","family":"Hiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mrfmmm.2025.111915_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0092-8674(00)80538-3","article-title":"hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization","volume":"90","author":"Meyerson","year":"1997","journal-title":"Cell"},{"issue":"18","key":"10.1016\/j.mrfmmm.2025.111915_bib2","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1073\/pnas.85.18.6622","article-title":"A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes","volume":"85","author":"Moyzis","year":"1988","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.mrfmmm.2025.111915_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceb.2017.12.001","article-title":"Telomeres and aging","volume":"52","author":"Shay","year":"2018","journal-title":"Curr. Opin. Cell Biol."},{"issue":"7","key":"10.1016\/j.mrfmmm.2025.111915_bib4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/sj.bjc.6603671","article-title":"Telomere and telomerase in stem cells","volume":"96","author":"Hiyama","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"1-2","key":"10.1016\/j.mrfmmm.2025.111915_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10616-004-5126-0","article-title":"Telomerase detection in the diagnosis and prognosis of cancer","volume":"45","author":"Hiyama","year":"2004","journal-title":"Cytotechnology"},{"key":"10.1016\/j.mrfmmm.2025.111915_bib6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.onc.1205070","article-title":"Clinical utility of telomerase in cancer","volume":"21","author":"Hiyama","year":"2002","journal-title":"Oncogene"},{"issue":"6122","key":"10.1016\/j.mrfmmm.2025.111915_bib7","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT promoter mutations in familial and sporadic melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.mrfmmm.2025.111915_bib8","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/sj.bjc.6602054","article-title":"High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma","volume":"91","author":"Hiyama","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.mrfmmm.2025.111915_bib9","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.jpedsurg.2011.09.003","article-title":"Wnt signaling and telomerase activation of hepatoblastoma: correlation with chemosensitivity and surgical resectability","volume":"46","author":"Ueda","year":"2011","journal-title":"J. Pedia Surg."},{"issue":"1","key":"10.1016\/j.mrfmmm.2025.111915_bib10","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1038\/s41467-021-25430-9","article-title":"Genetic and epigenetic basis of hepatoblastoma diversity","volume":"12","author":"Nagae","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.mrfmmm.2025.111915_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10014-021-00403-4","article-title":"Droplet digital PCR assay for detecting TERT promoter mutations in patients with glioma","volume":"38","author":"Adachi","year":"2021","journal-title":"Brain Tumor Pathol."},{"issue":"8","key":"10.1016\/j.mrfmmm.2025.111915_bib12","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/nprot.2008.112","article-title":"PCR-amplification of GC-rich regions: 'slowdown PCR","volume":"3","author":"Frey","year":"2008","journal-title":"Nat. Protoc."},{"issue":"45","key":"10.1016\/j.mrfmmm.2025.111915_bib13","doi-asserted-by":"crossref","first-page":"27014","DOI":"10.1074\/jbc.270.45.27014","article-title":"Pausing of DNA synthesis in vitro at specific loci in CTG and CGG triplet repeats from human hereditary disease genes","volume":"270","author":"Kang","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.mrfmmm.2025.111915_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju246","article-title":"TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma","volume":"106","author":"Griewank","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.mrfmmm.2025.111915_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/neuonc\/noy167","article-title":"Sensitive and rapid detection of TERT promoter and IDH mutations in diffuse gliomas","volume":"21","author":"Diplas","year":"2019","journal-title":"Neuro Oncol."},{"issue":"8","key":"10.1016\/j.mrfmmm.2025.111915_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082228","article-title":"Design and testing of a custom melanoma next generation sequencing panel for analysis of circulating tumor DNA","volume":"12","author":"Diefenbach","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.mrfmmm.2025.111915_bib17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jmoldx.2020.10.016","article-title":"Spatial distribution patterns of clinically relevant TERT promoter mutations in follicular thyroid tumors of uncertain malignant potential: advantages of the digital droplet PCR technique","volume":"23","author":"Hysek","year":"2021","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.mrfmmm.2025.111915_bib18","series-title":"A Laboratory Manual","article-title":"Molecular cloning","author":"Sambrook","year":"1989"},{"issue":"8","key":"10.1016\/j.mrfmmm.2025.111915_bib19","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1002\/cam4.1666","article-title":"The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI-derived and clinical features, predict adult primary glioblastoma survival","volume":"7","author":"Shu","year":"2018","journal-title":"Cancer Med"},{"issue":"12","key":"10.1016\/j.mrfmmm.2025.111915_bib20","doi-asserted-by":"crossref","first-page":"10259","DOI":"10.18632\/oncotarget.21982","article-title":"Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors","volume":"9","author":"Mehrotra","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.mrfmmm.2025.111915_bib21","article-title":"Feasibility of dose-dense cisplatin-based chemotherapy in Japanese children with high-risk hepatoblastoma: analysis of the JPLT3-H pilot study","author":"Watanabe","year":"2021","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.mrfmmm.2025.111915_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31255","article-title":"Successful treatment of young childhood standard-risk hepatoblastoma with cisplatin monotherapy using a central review system","author":"Saeki","year":"2024","journal-title":"Pedia Blood Cancer"},{"issue":"6","key":"10.1016\/j.mrfmmm.2025.111915_bib23","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1309\/AJCPMWGWGO34EGOD","article-title":"Clinical validation of KRAS, BRAF, and EGFR mutation detection using next-generation sequencing","volume":"141","author":"Lin","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.mrfmmm.2025.111915_bib24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2353\/jmoldx.2010.090188","article-title":"Comparison of sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications","volume":"12","author":"Tsiatis","year":"2010","journal-title":"J. Mol. Diagn."},{"issue":"3","key":"10.1016\/j.mrfmmm.2025.111915_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10030728","article-title":"Detection of TERT promoter mutations as a prognostic biomarker in gliomas: methodology, prospects, and advances","volume":"10","author":"Hasanau","year":"2022","journal-title":"Biomedicines"},{"issue":"15","key":"10.1016\/j.mrfmmm.2025.111915_bib26","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.clinbiochem.2014.12.007","article-title":"Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR","volume":"48","author":"Reid","year":"2015","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.mrfmmm.2025.111915_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10014-018-0310-7","article-title":"A novel high-sensitivity assay to detect a small fraction of mutant IDH1 using droplet digital PCR","volume":"35","author":"Hirano","year":"2018","journal-title":"Brain Tumor Pathol."},{"issue":"1","key":"10.1016\/j.mrfmmm.2025.111915_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11060-020-03682-7","article-title":"Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid","volume":"152","author":"Fujioka","year":"2021","journal-title":"J. Neurooncol."},{"issue":"2","key":"10.1016\/j.mrfmmm.2025.111915_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/10935266231204788","article-title":"Molecular profiling of a hepatocellular neoplasm not otherwise specified (HCN-NOS) demonstrates distinct molecular features in hepatoblastoma and HCC-Like components","volume":"27","author":"Chen Wongworawat","year":"2024","journal-title":"Pedia Dev. Pathol."},{"issue":"7","key":"10.1016\/j.mrfmmm.2025.111915_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7043","article-title":"Identification of molecular characteristics of hepatocellular carcinoma with microvascular invasion based on deep targeted sequencing","volume":"13","author":"Zheng","year":"2024","journal-title":"Cancer Med."},{"issue":"14","key":"10.1016\/j.mrfmmm.2025.111915_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14143367","article-title":"Circulating cell-free DNA profiling predicts the therapeutic outcome in advanced hepatocellular carcinoma patients treated with combination immunotherapy","volume":"14","author":"Matsumae","year":"2022","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.mrfmmm.2025.111915_bib32","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/gutjnl-2024-331956","article-title":"Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments","volume":"73","author":"Campani","year":"2024","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.mrfmmm.2025.111915_bib33","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1159\/000540438","article-title":"Changes in mutations of Cell-Free DNA and liver tumor tissue in patients with advanced hepatocellular carcinoma before and after introduction of lenvatinib","volume":"102","author":"Tsuruoka","year":"2024","journal-title":"Oncology"},{"key":"10.1016\/j.mrfmmm.2025.111915_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148646","article-title":"A systematic analysis with the hierarchical cluster analysis strategy on the complex interaction of TERT and CTNNB1 somatic mutations in Vietnamese hepatocellular carcinoma patients","volume":"927","author":"Thu Nguyen","year":"2024","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.mrfmmm.2025.111915_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/biom14060656","article-title":"Molecular mechanisms in tumorigenesis of hepatocellular carcinoma and in target treatments-an overview","volume":"14","author":"Szilveszter","year":"2024","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.mrfmmm.2025.111915_bib36","first-page":"551","article-title":"Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors","volume":"15","author":"Yamaoka","year":"2006","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.mrfmmm.2025.111915_bib37","first-page":"901","article-title":"Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma","volume":"7","author":"Takayasu","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.mrfmmm.2025.111915_bib38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3892\/ol.2021.13140","article-title":"Direct molecular evidence for both multicentric and monoclonal carcinogenesis followed by transdifferentiation from hepatocellular carcinoma to cholangiocarcinoma in a case of metachronous liver cancer","volume":"23","author":"Ohni","year":"2022","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.mrfmmm.2025.111915_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31770","article-title":"Treatment of intermediate\u2010risk hepatoblastoma using a combined cisplatin and doxorubicin (PLADO) regimen and optimized surgical resection","volume":"72","author":"Hishiki","year":"2025","journal-title":"Pediatr. Blood Cancer"}],"container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510725000181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510725000181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:09:06Z","timestamp":1777388946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027510725000181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":39,"alternative-id":["S0027510725000181"],"URL":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2025.111915","relation":{},"ISSN":["1386-1964"],"issn-type":[{"value":"1386-1964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of TERT promoter hotspot mutations using droplet digital PCR in\u00a0hepatoblastoma and hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2025.111915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111915"}}